Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use in hospitals.
Clinical Benefit
| Substantial |
Le service médical rendu par cette spécialité est important dans l’indication de l’AMM.
|
Clinical Added Value
| moderate |
INCRELEX apporte une amélioration du service médical rendu modérée (ASMR III) dans la prise en charge des enfants et adolescents (2 à 16 ans) présentant des retards de croissance dus à un déficit primaire sévère en IGF-1 (IGFD primaire).
|
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
J6JwuhbGALPpmZhW
